India is failing to take advantage of its important ally, Japan as much as it should, notes Mihir S Sharma. India's most important bilateral relationship may not be with the United States, or......
Pfizer has taken Ranbaxy Laboratories to court in the US, alleging infringement of its patent on Accupril (generic name: quinapril), an anti-hypertensive with annual sales of $550 million.Teva of......
India's Sun Pharmaceutical Industries Ltd has agreed to buy generic drugmaker Ranbaxy Laboratories Ltd for $3.2 billion, betting it can fix factory quality glitches that plagued the current owner,......
The merger gets Punjab & Haryana High Court go-ahead; deal to close after brand dilutions The $4-billion merger between Sun Pharmaceutical Industries and Ranbaxy Laboratories has crossed the final......
The Competition Commission of India and the US Federal Trade Commission are yet to give their nod to the biggest pharma merger and acquisition deal this year in the Asia-Pacific region Sun......
Indicating a shift in its business strategy, drugmaker Ranbaxy could withdraw from some global markets in the near future, while consolidating in others. According to sources, the company has......